Log in

OTCMKTS:EMHTFEmerald Health Therapeutics Stock Price, Forecast & News

$0.16
+0.01 (+6.69 %)
(As of 05/22/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.14
Now: $0.16
$0.17
50-Day Range
$0.10
MA: $0.12
$0.19
52-Week Range
$0.07
Now: $0.16
$2.90
Volume889,601 shs
Average Volume380,713 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis in Canada. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Victoria, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.42 out of 5 stars


Industry, Sector and Symbol

Industry Oil & Gas Production
Sub-IndustryN/A
SectorEnergy Minerals
Current SymbolOTCMKTS:EMHTF
CUSIPN/A
CIKN/A
Phone(800) 757-3536

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees24
Next Earnings DateN/A
OptionableNot Optionable

Receive EMHTF News and Ratings via Email

Sign-up to receive the latest news and ratings for EMHTF and its competitors with MarketBeat's FREE daily newsletter.

Emerald Health Therapeutics (OTCMKTS:EMHTF) Frequently Asked Questions

How has Emerald Health Therapeutics' stock been impacted by COVID-19 (Coronavirus)?

Emerald Health Therapeutics' stock was trading at $0.1450 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, EMHTF shares have increased by 9.9% and is now trading at $0.1594. View which stocks have been most impacted by Coronavirus.

Has Emerald Health Therapeutics been receiving favorable news coverage?

News headlines about EMHTF stock have been trending extremely negative on Sunday, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Emerald Health Therapeutics earned a media sentiment score of -4.6 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the next few days. View the latest news aboutEmerald Health Therapeutics.

Who are some of Emerald Health Therapeutics' key competitors?

Who are Emerald Health Therapeutics' key executives?

Emerald Health Therapeutics' management team includes the following people:
  • Dr. Avtar S. Dhillon, Exec. Chairman & Pres (Age 57)
  • Mr. Robert C. Hill CPA, CPA, CA, CFO & Corp. Sec.
  • Mr. Christopher W. Wagner, Consultant (Age 50)
  • Mr. Michael Bierman, VP of Operations
  • Mr. Allan Rewak, VP of Communications & Stakeholder Relations

What is Emerald Health Therapeutics' stock symbol?

Emerald Health Therapeutics trades on the OTCMKTS under the ticker symbol "EMHTF."

How do I buy shares of Emerald Health Therapeutics?

Shares of EMHTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Emerald Health Therapeutics' stock price today?

One share of EMHTF stock can currently be purchased for approximately $0.16.

What is Emerald Health Therapeutics' official website?

The official website for Emerald Health Therapeutics is www.emerald.care.

How can I contact Emerald Health Therapeutics?

The company can be reached via phone at (800) 757-3536.

This page was last updated on 5/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.